Literature DB >> 3257781

Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells.

D Campana1, E Coustan-Smith, G Janossy.   

Abstract

New methods for double and triple colour labelling using monoclonal antibodies to the proliferation-associated markers 5-bromo-2'-deoxyuridine (BrdU) and Ki67 are described. In order to make incorporated BrdU accessible to most anti-BrdU antibodies, mild denaturation of the DNA is needed, and this is usually obtained by exposing the cells to acid or base. This procedure destroys most cellular antigens, including nuclear TdT and Ki67. In this study we show that fixation in cold methanol, instead of 70% ethanol, for 30 min followed by immersion in 7 X 10(-3) N NaOH for 10-15 s allows BrdU staining with the simultaneous detection of nuclear, cytoplasmic and membrane antigens as well as preservation of morphological detail. This method is optimal for detection of nuclear Ki67 and TdT. These reagents together with antibodies to membrane antigens can be included in triple colour labelling using second layers conjugated to FITC, TRITC and colloidal gold. With these methods it is now possible to characterize the phenotype of dividing cell populations such as precursors in central lymphoid tissues and germinal centre blasts in peripheral lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257781     DOI: 10.1016/0022-1759(88)90012-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  Bromodeoxyuridine (BrdU) immunocytochemistry by exonuclease III (Exo III) digestion.

Authors:  W N Dinjens; J ten Kate; M H Lenders; E P van der Linden; F T Bosman
Journal:  Histochemistry       Date:  1992-10

2.  Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67.

Authors:  I Cordone; E Matutes; D Catovsky
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

3.  Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.

Authors:  Preethi Korangath; Wei Wen Teo; Helen Sadik; Liangfeng Han; Noriko Mori; Charlotte M Huijts; Flonne Wildes; Santosh Bharti; Zhe Zhang; Cesar A Santa-Maria; Hualing Tsai; Chi V Dang; Vered Stearns; Zaver M Bhujwalla; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2015-03-26       Impact factor: 12.531

4.  Two-colour immunoenzymatic technique using sequential staining by APAAP to evaluate two cell antigens.

Authors:  R Burgess; K Hyde; P J Maguire; P R Kelsey; J A Yin; C G Geary
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

5.  Proliferative and functional stages of rat ameloblast differentiation as revealed by combined immunocytochemistry against enamel matrix proteins and bromodeoxyuridine.

Authors:  A Casasco; A Calligaro; M Casasco
Journal:  Cell Tissue Res       Date:  1992-12       Impact factor: 5.249

6.  Phenotypic changes and proliferative activity of human gamma delta T cell receptor-bearing cells upon activation.

Authors:  S Ho; D Campana
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor.

Authors:  A A Irani; G Nilsson; L K Ashman; L B Schwartz
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

8.  The tissue distribution of T lymphocytes expressing different CD45 polypeptides.

Authors:  G Janossy; M Bofill; D Rowe; J Muir; P C Beverley
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

9.  The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species.

Authors:  S L Kozak; D C Siess; M P Kavanaugh; A D Miller; D Kabat
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.

Authors:  Grzegorz B Gmyrek; Adrian Filiberti; Micaela Montgomery; Alisha Chitrakar; Derek J Royer; Daniel J J Carr
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.